QYLG: Covered Calls On The NDX, But In Its Own Way (NASDAQ:QYLG)
QYLG: Covered Calls On The NDX, But In Its Own Way Source link
QYLG: Covered Calls On The NDX, But In Its Own Way Source link
Washington H. Soul Pattinson and Co. Limited’s (SOL) principal activities include ownership of shares and properties, coal mining and retailing of pharmaceutical products. The company’s main operating subsidiaries are New Hope Corporation and Pitt Capital Partners. http://www.whsp.com.au Source link
The last couple of weeks have been ugly. Gold dropped sharply, silver even harder, and the “AI disruption” favourites over in tech land finally cracked and pulled down the big indices. And with them, small-caps and micro-caps were forced lower. On your screen it looks like one trade breaking. In reality, I think it was…
Source: Investor Presentation of Godrej Properties Ltd Source link
Source link
Shares of retailer Kalyan Jewellers India hit the 10% upper circuit limit on BSE, surging to Rs 417.75, as the jewellery retailer’s blockbuster third-quarter earnings triggered a wave of bullish brokerage calls with price targets as high as Rs 750, a potential 80% upside from current levels. The stock locked into the circuit after the…
Over the last few months, I’ve been writing about the need to focus on energy stocks. I hope you’ve been paying attention because not many have! Especially with the supposed oversupply in the oil and gas market. But as I’ve mentioned before, the price leads the news. Official reports often don’t align with the reality…
Tokyo’s Nikkei 225 share index has jumped 4.7% after Japanese Prime Minister Sanae Takaichi’s governing party secured a two-thirds supermajority in a parliamentary election Source link
Some stuff I am reading today morning: Japanese stocks hit record highs (CNBC) Why Indian markets have bottomed out (Samit Vartak) The Index is lying to you (Capitalmind MF) India, Malaysia sign 11 agreements (BS) Not easy for India to cut Russian oil (OP) The different races in AI (Aakash Gupta) AI boom is causing…
Hims to stop offering GLP-1 pill after FDA warned of crackdown Source link